Granules India intimates of successful USFDA inspection of Gagillapur facility

Located at Hyderabad, Telangana

Granules India announced that Company's Gagillapur facility located at Hyderabad, Telangana, India has successfully completed US FDA inspection without any observations. This facility manufactures Finished Dosages (FDs) and Pharmaceutical Formulation Intermediates (PFIs).

Powered by Capital Market - Live News